Compare NEN & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
Current Price
Current Price
| Metric | NEN | CBUS |
|---|---|---|
| Founded | 1977 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building operators | Agricultural Chemicals |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 227.9M | 208.7M |
| IPO Year | 1995 | 2017 |
| Metric | NEN | CBUS |
|---|---|---|
| Price | $62.26 | $3.72 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 1.5K | ★ 525.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 7.71% | N/A |
| EPS Growth | N/A | ★ 58.27 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $80,532,550.00 | $4,262,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $99.13 |
| P/E Ratio | $19.68 | ★ N/A |
| Revenue Growth | N/A | ★ 134.56 |
| 52 Week Low | $62.00 | $1.09 |
| 52 Week High | $84.00 | $3.80 |
| Indicator | NEN | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 47.35 | 64.84 |
| Support Level | $62.05 | $1.34 |
| Resistance Level | $66.30 | N/A |
| Average True Range (ATR) | 0.63 | 0.32 |
| MACD | 0.17 | -0.02 |
| Stochastic Oscillator | 65.00 | 82.18 |
New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating and selling real estate. The Partnership owns and operates various residential apartments, condominium units and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.